What is AOD-9604?
AOD-9604 is a modified fragment of human growth hormone — specifically the tail end of the molecule (amino acids 176–191) that researchers linked to its fat-burning activity.1 The goal was elegant: isolate the part that mobilizes fat, and leave behind the parts that affect blood sugar and tissue growth.
It’s a good example of where honesty matters most. The concept is compelling and early animal data was encouraging — but when tested in humans, AOD-9604 has not consistently delivered meaningful weight loss.2 We label it Emerging, not proven.
Benefits & what it’s studied for
Its central premise — stimulating the breakdown of stored fat and limiting new fat formation, shown mainly in laboratory and animal models.1
It has also been explored for metabolic and cartilage/joint applications, but these remain early-stage and inconclusive.2
For weight loss specifically, human results have been disappointing relative to the hype — and far weaker than approved GLP-1 options.2
How does AOD-9604 work?
AOD-9604 is designed to mimic the way growth hormone stimulates fat metabolism — encouraging fat cells to release and burn stored fat — while, in theory, not acting on the IGF-1 pathway that raises blood sugar and drives tissue growth.1 The appeal is a “fat-only” growth-hormone effect; the reality in humans has been more modest than the mechanism suggests.
Dosing & administration
The bigger caveat is efficacy and long-term data: human evidence is limited, and lasting safety isn’t established.
This is educational, not medical advice. We don’t publish dosing. Given the limited evidence, any use should be discussed with a licensed provider who can weigh it against better-supported options. Not evaluated by the FDA.
Legality & status
AOD-9604 is not FDA-approved as a weight-loss drug. It has appeared in research and supplement contexts over the years, but that’s not the same as approval. Legitimate access is through a licensed provider and compounding pharmacy where permitted — and a good provider may well steer you toward better-evidenced options. See how legitimate peptide therapy works.
Thinking about AOD-9604?
Talk to a licensed provider who can tell you if it fits your goals — and build a safe protocol.
Research & references
- 1Heffernan M, et al. The GH fragment AOD-9604 and fat metabolism — mechanism & preclinical work. link pending
- 2Human clinical trial of AOD-9604 for weight loss (limited efficacy). Citation to be finalized. link pending
Reference links are illustrative placeholders — replace with verified PubMed/journal URLs before publishing.
Frequently asked questions
What is AOD-9604 used for?+
AOD-9604 is a fragment of growth hormone studied for fat metabolism — the idea being to target fat breakdown without the broader growth-hormone effects on blood sugar or tissue growth. Human evidence for meaningful weight loss is limited and mixed.
Does AOD-9604 actually cause weight loss?+
Early animal work was promising, but human clinical trials have not consistently shown significant weight loss. The honest summary is that the evidence is limited and far weaker than for approved options like GLP-1 medications.
Is AOD-9604 FDA-approved?+
No. AOD-9604 is not FDA-approved as a weight-loss drug. It has been examined in food/supplement and research contexts, but it is not an approved therapeutic; access is via a licensed provider where permitted.
Is AOD-9604 safe?+
long-term human safety data is limited. Use should be supervised by a provider.
How is AOD-9604 different from tesamorelin?+
AOD-9604 is a fragment of growth hormone aimed directly at fat metabolism, while tesamorelin is a GHRH analog that raises the body’s own growth hormone and is FDA-approved for visceral fat. Tesamorelin has far stronger evidence.